Publications by authors named "Matthew Macaluso"

Claim this Profile
E
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Matthew Macaluso

J Affect Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Adam Janik, Xin Qiu, Rosanne Lane, Vanina Popova, Wayne C Drevets, Matthew Macaluso

JAMA Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of Life.
Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Matthew Macaluso

J Clin Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report.
Scott T Aaronson, Charles R Conway, Charles Gordon, Ying-Chieh Lisa Lee, Mark S George, Matthew Macaluso

J Clin Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Mark S George, John Zajecka, Matthew Macaluso

Brain Stimul· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature.
Andrew Toyin Olagunju, Jeffrey Wang, Bassey Edet, Obiora E Onwuameze, Matthew Macaluso

J Psychiatr Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
George I Papakostas, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Michael E Thase, Matthew Macaluso

Mol Psychiatry· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Can You Learn About Psychiatry Programs from Their Website? A Content Evaluation for Potential Applicants.
Austin G Armstrong, Kenneth W Fraser, Shelby N Nix, Rosalee Zackula, Rachel Brown, Matthew Macaluso

Acad Psychiatry· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.
Ibrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, Stephane Borentain, Matthew Macaluso

Psychiatry Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the relationship between personality pathology and attachment style in the context of the DSM-5 Alternative Model of Personality Disorders.
Rachel A Pad, Hayrettin Okut, Rosey Zackula, Matthew Macaluso, Steven K Huprich

Personal Ment Health· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RORγt-Expressing Pathogenic CD4 T Cells Cause Brain Inflammation during Chronic Colitis.
Michel Edwar Mickael, Suniti Bhaumik, Ayanabha Chakraborti, Alan A Umfress, Thomas van Groen, Matthew Macaluso

J Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-Methylfolate in Antidepressant Non-responders: The Impact of Body Weight and Inflammation.
Matthew Macaluso

Front Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder.
Sagar V Parikh, Rebecca A Law, Daniel T Hain, Anthony J Rothschild, Michael E Thase, Matthew Macaluso

Psychiatry Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19.
Kimberly Smith, Rebekah Kummer, Matthew Macaluso

Prim Care Companion CNS Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Asian and American pedagogy to improve clinical psychopharmacology practice.
Andrew T Olagunju, Matthew Macaluso, Ira D Glick

Asian J Psychiatr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.
Jess G Fiedorowicz, Lisa Brown, James Li, Sagar V Parikh, Boadie W Dunlop, Matthew Macaluso

Psychopharmacol Bull· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatry Milestones 2.0: Using the Supplemental Guide to Create a Shared Model of the Development of Professional Identity and Expertise.
J Mark Kinzie, Sandra M DeJong, Laura Edgar, L Joy Houston, Furhut Janssen, Matthew Macaluso

Acad Psychiatry· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Much Education and Training Do Residents Across Specialties Receive in Neuropsychology?
Seher Chowhan, Phillip K Martin, Matthew Macaluso, Christina Bowman, Ryan W Schroeder

Kans J Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM Studies.
Ibrahim Turkoz, Ella Daly, Jaskaran Singh, Xiwu Lin, Yevgen Tymofyeyev, Matthew Macaluso

J Clin Psychiatry· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset.
Nadia Iovieno, George I Papakostas, Anna Feeney, Maurizio Fava, Sanjay J Mathew, Matthew Macaluso

J Clin Psychiatry· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
Anthony J Rothschild, Sagar V Parikh, Daniel Hain, Rebecca Law, Michael E Thase, Matthew Macaluso

Psychiatry Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
Brent P Forester, Sagar V Parikh, Sara Weisenbach, Olusola Ajilore, Ipsit Vahia, Matthew Macaluso

Focus (Am Psychiatr Publ)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.
Maurizio Fava, Erica Mazzone, Marlene Freeman, Martina Flynn, Heidi Judge, Matthew Macaluso

Ann Clin Psychiatry· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis